The present study focussed on promoter methylation of four known Wnt-pathway antagonists (SFRP2, WIF-1, DKK3 and SOX17), in polypoid and nonpolypoid adenomas, and its possible association with other molecular events that can play a role in Wnt-pathway activation. Here, DKK3 is linked to adenoma.